This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Dr Fuh is an ...

Understanding why cancer cells rely on specific genes is critical for designing effective targeted therapies. A new study ...

A new study by the National Cancer Research Center (CNIO) has identified several sets of genes related to the predisposition ...

Mainz Biomed N.V. (NASDAQ: MYNZ), a molecular genetics diagnostic company specializing in the early detection of cancer, is ...

Scientist examining genetic testing results on a screen High-grade tumors do not directly evolve from lower-grade ones, but both likely emerge from a common, pre-malignant mutagenic field. A recent ...

Much of pancreatic cancer’s evasive and deadly nature may come down to low levels of one gene. In A Nutshell Early detection, ...

Of all the types of breast cancer, triple negative breast cancer (TNBC) is the most aggressive and lacks specific therapies.

CNIO researchers identified complement system genes linked to pancreatic cancer susceptibility and prognosis. Mutations in ...

Myriad Genetics, Inc. has announced a strategic collaboration with PATHOMIQ, Inc., which allows Myriad to exclusively license PATHOMIQ_PRAD, an AI technology platform for prostate cancer diagnostics ...